X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (662) 662
index medicus (634) 634
female (413) 413
animals (343) 343
folic acid (334) 334
cancer (251) 251
oncology (226) 226
expression (187) 187
folate (187) 187
folate receptor-alpha (186) 186
folic acid - metabolism (173) 173
folate receptor (171) 171
mice (169) 169
male (156) 156
ovarian cancer (153) 153
vitamin b (135) 135
folate receptors, gpi-anchored (129) 129
middle aged (124) 124
article (123) 123
cell line, tumor (122) 122
tumors (122) 122
biochemistry & molecular biology (119) 119
pharmacology & pharmacy (113) 113
binding-protein (112) 112
adult (108) 108
folate receptor 1 - metabolism (108) 108
folate receptor alpha (107) 107
folic-acid (106) 106
health aspects (104) 104
chemotherapy (103) 103
aged (99) 99
research (98) 98
dna methylation (96) 96
pregnancy (90) 90
cells (86) 86
gene expression (84) 84
ovarian-cancer (80) 80
cell biology (78) 78
carrier proteins - genetics (74) 74
analysis (72) 72
nanoparticles (72) 72
carrier proteins - metabolism (68) 68
medicine, research & experimental (68) 68
in-vitro (66) 66
care and treatment (65) 65
folic acid - chemistry (65) 65
ovarian neoplasms - pathology (64) 64
physiological aspects (63) 63
immunotherapy (62) 62
in-vivo (62) 62
risk factors (62) 62
metabolism (61) 61
drug delivery systems (60) 60
homocysteine (59) 59
genetics & heredity (58) 58
proteins (57) 57
breast-cancer (56) 56
carcinoma (56) 56
immunohistochemistry (56) 56
prognosis (56) 56
therapy (56) 56
folate receptor 1 - genetics (55) 55
folic acid - administration & dosage (55) 55
methylation (55) 55
cancer therapies (54) 54
genetic aspects (53) 53
folic acid - pharmacology (52) 52
rats (52) 52
medicine (51) 51
alpha (50) 50
neural-tube defects (50) 50
receptors, cell surface - metabolism (50) 50
review (50) 50
surgery (50) 50
breast cancer (49) 49
ovarian neoplasms - drug therapy (48) 48
risk (48) 48
receptor-alpha (47) 47
receptors, cell surface - genetics (47) 47
cell line (46) 46
medicine & public health (46) 46
receptors, cell surface (46) 46
antitumor-activity (45) 45
identification (45) 45
biomarkers (44) 44
case-control studies (44) 44
nanoscience & nanotechnology (43) 43
delivery (42) 42
gene (42) 42
genes (42) 42
methotrexate (42) 42
methylenetetrahydrofolate reductase (42) 42
binding (41) 41
reduced folate carrier (41) 41
apoptosis (40) 40
biotechnology & applied microbiology (40) 40
drug-delivery (40) 40
lung cancer (40) 40
monoclonal-antibody (40) 40
nutrition & dietetics (40) 40
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 01/2013, Volume 8, Issue 1, pp. 19 - 30
Journal Article
STEM CELLS, ISSN 1066-5099, 11/2016, Volume 34, Issue 11, pp. 2721 - 2732
Prenatal folic acid (FA) supplementation prevents neural tube defects. Folate receptor alpha (FRα) is critical for embryonic development, including neural... 
Oct4 | Sox2 | Enhancer/promoters | Folate receptor alpha | miR‐138 | Multipotency | Klf4 | miR‐let‐7 | Cranial neural crest cells | miR-138 | miR-let-7 | SURVIVAL | TUBE | TRANSCRIPTIONAL NETWORK | MOUSE | PAX3 | PLURIPOTENCY | MICRORNAS | FOLIC-ACID | CELL & TISSUE ENGINEERING | CELL BIOLOGY | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | EMBRYONIC STEM-CELLS | TARGET GENE | HEMATOLOGY | RNA, Small Interfering - genetics | RNA-Binding Proteins - genetics | Folic Acid - pharmacology | MicroRNAs - antagonists & inhibitors | Transcriptional Activation | MicroRNAs - metabolism | Neural Stem Cells - cytology | SOXB1 Transcription Factors - agonists | Neural Crest - metabolism | SOXB1 Transcription Factors - metabolism | Octamer Transcription Factor-3 - genetics | SOXB1 Transcription Factors - genetics | p300-CBP Transcription Factors - genetics | Gene Expression Regulation, Developmental | Kruppel-Like Transcription Factors - agonists | Kruppel-Like Transcription Factors - metabolism | PAX3 Transcription Factor - genetics | Female | Promoter Regions, Genetic | Neural Crest - cytology | Ribonuclease III - genetics | Ribonuclease III - metabolism | Signal Transduction | Neural Stem Cells - drug effects | PAX3 Transcription Factor - deficiency | Folate Receptor 1 - antagonists & inhibitors | Transcription Factors - genetics | Mice, Knockout | Neural Crest - drug effects | Octamer Transcription Factor-3 - agonists | Transcription Factors - metabolism | p300-CBP Transcription Factors - metabolism | Animals | Histones - genetics | Folate Receptor 1 - genetics | Folate Receptor 1 - metabolism | Octamer Transcription Factor-3 - metabolism | Folic Acid - metabolism | Protein Binding | Mice | MicroRNAs - genetics | Histones - metabolism | Antagomirs - metabolism | Antagomirs - genetics | Kruppel-Like Transcription Factors - genetics | Neural Stem Cells - metabolism | RNA-Binding Proteins - metabolism | RNA, Small Interfering - metabolism | Embryonic development | Chromatin | Biosynthesis | MicroRNA | Folic acid | Stem cells | Genes | Cell proliferation | Immunoprecipitation | Oct-4 protein | Effector cells | Event-related potentials | Nuclei | Defects | Embryogenesis | KLF4 protein | Coding | miRNA | Supplementation | Prenatal experience | Neural tube defects | Neural crest | Promoters | Embryonic growth stage | Polymerase chain reaction | Gene silencing | Neural stem cells | Skull
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2017, Volume 35, Issue 10, pp. 1112 - 1118
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2007, Volume 108, Issue 3, pp. 619 - 626
Abstract Objectives. Folate receptor α (FRα) is a folate-binding protein overexpressed on ovarian and several other epithelial malignancies that can be used as... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Folate receptor | Ovarian cancer | 5-METHYLTETRAHYDROFOLATE | VIVO | ovarian cancer | BINDING-PROTEIN | folate receptor | CELL-GROWTH | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | IN-VITRO | ONCOLOGY | TISSUES | IMAGING AGENTS | EXPRESSION | CARCINOMA | Immunohistochemistry | Folate Receptors, GPI-Anchored | Adenocarcinoma, Mucinous - pathology | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | Cystadenocarcinoma, Serous - pathology | Neoplasm Recurrence, Local - mortality | Cystadenocarcinoma, Serous - drug therapy | Carcinoma, Endometrioid - metabolism | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasm Metastasis | Female | Ovarian Neoplasms - metabolism | Retrospective Studies | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Carcinoma, Endometrioid - genetics | Neoplasm Recurrence, Local - metabolism | Adenocarcinoma, Clear Cell - metabolism | Medical Records | Receptors, Cell Surface - metabolism | Minnesota | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma, Mucinous - mortality | Carrier Proteins - genetics | Disease-Free Survival | Carrier Proteins - metabolism | Carcinoma, Endometrioid - mortality | Adenocarcinoma, Mucinous - metabolism | Survival Analysis | Cystadenocarcinoma, Serous - mortality | Neoplasm Recurrence, Local - genetics | Adenocarcinoma, Clear Cell - pathology | Adenocarcinoma, Mucinous - genetics | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Adenocarcinoma, Clear Cell - drug therapy | Receptors, Cell Surface - genetics | Folic acid
Journal Article
NEOPLASIA, ISSN 1476-5586, 12/2016, Volume 18, Issue 12, pp. 775 - 784
Elevated folate receptor alpha (FR alpha) expression is characteristic of epithelial ovarian cancer (EOC), thus establishing this receptor as a candidate... 
TREATMENT OPTIONS | CARBOPLATIN | THERAPY | ONCOLOGY | BEVACIZUMAB | PHASE-III | VINTAFOLIDE EC145 | HISTONE H2AX | COMBINATION | EMERGING CONCEPT | PACLITAXEL
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 05/2016, Volume 7, Issue 22, pp. 32144 - 32155
Journal Article